Outsourced Pharma Capacity Update Videos - Cell & Gene
-
Andelyn Biosciences Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
Discover our innovative DOE-based strategy for developing a scalable suspension platform to produce and purify AAV vectors, optimizing consistency, productivity, and quality across scales.
-
FUJIFILM Diosynth Biotechnologies Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
Here, we showcase our investment in cell therapy services and explore the innovative designs and expansions at the Thousand Oaks facility that will enhance GMP production capabilities.
-
IDT Biologika Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
With over 30 years of GMP manufacturing expertise, we offer dedicated capacity for clinical and commercial gene therapy batches, using advanced AAV platforms and proprietary cell lines.
-
SK pharmteco Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
Check out our enhanced capacity and expertise in supporting CGT projects, offering end-to-end solutions from viral vector and plasmid development to GMP manufacturing and regulatory support.